Stay aware of the latest advances from the academic thought leaders and expert clinicians of the Department of Psychiatry at Mount Sinai. Led by René Kahn, MD, PhD, our team is at the forefront of unlocking the complex interactions between biological processes and the myriad states of the human mind. Ranked No. 5 among the nation's psychiatry departments for National Institute of Health funding, Mount Sinai is unrelenting in its commitment to advancing life-changing treatment. The Department is a vibrant community of psychiatric clinicians, researchers, educators, and trainees, and is a national model for groundbreaking clinical research in neuropsychiatry. Our programs offer a wide range of diagnostic and treatment services for conditions ranging from addiction, to major depression, autism, and schizophre
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Stay aware of the latest advances from the academic thought leaders and expert clinicians of the Department of Psychiatry at Mount Sinai. Led by René Kahn, MD, PhD, our team is at the forefront of unlocking the complex interactions between biological processes and the myriad states of the human mind. Ranked No. 5 among the nation's psychiatry departments for National Institute of Health funding, Mount Sinai is unrelenting in its commitment to advancing life-changing treatment. The Department is a vibrant community of psychiatric clinicians, researchers, educators, and trainees, and is a national model for groundbreaking clinical research in neuropsychiatry. Our programs offer a wide range of diagnostic and treatment services for conditions ranging from addiction, to major depression, autism, and schizophre
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Latest Videos
Video
From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry
Listen as Mount Sinai neuroscientists discuss ketamine, cannabis, and ecstasy as potential treatments for treatment-resistant depression, opioid addiction, and post-traumatic stress disorder
Video
How Epidemics Affect Our Mental Health
Craig Katz, MD, Director of Mount Sinai’s Global Mental Health Program, delivers a Grand Rounds presentation on the behavioral sequelae of epidemics.
Video
How to Use Psychological First Aid to Prevent Post-Disaster Psychopathology
Craig Katz, MD, Director of Mount Sinai’s Program in Global Mental Health, breaks down how to deliver psychological first aid in a disaster setting in order to prevent post-disaster psychopathology.
Video
Repeated Ketamine Infusions Reduce Symptom Severity in Chronic Post-Traumatic Stress Disorder
Repeated intravenous ketamine infusions significantly reduce symptom severity in individuals with post-traumatic stress disorder and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by ...
Video
STOP COVID NYC: A Study Capturing City-Wide Coronavirus Symptoms and Mental Health Impacts
Laura Huckins, PhD, Assistant Professor of Psychiatry, and Genetics and Genomic Sciences, discusses a new app-based survey gathering data on New York City residents and their COVID-19-related symptoms in order to better understand transmission ...
Video
CBD for Treating Opioid Addiction
Dr. Hurd’s latest study showed that CBD reduces cravings and anxiety in patients with heroin use disorder.
Video
Intergenerational Effects of Trauma: A Biological Perspective
Rachel Yehuda, PhD, discusses how trauma from previous generations can affect descendants from an epigenetic standpoint.
Video
New Frontiers for Depression: Deep Brain Stimulation, Esketamine, and the Immune System
“In five years, we expect to have a range of new treatments available targeting people with different forms of depression that work effectively, specifically for them.” –Eric Nestler, MD, PhD
Video
René Kahn, MD, PhD: Tackling the Neurobiology of Schizophrenia
Dr. Kahn discusses how brain changes in schizophrenic patients are related to disease progression and outcomes.
Video
An App-Based Game to Treat Depression
It looks and works like a game, but it acts like medicine—with no side effects.
Video
From Genes to Treatment: Using Rare Genetic Disorders to Develop Novel Therapeutics
Dr. Kolevzon’s talk at the Seaver Autism Center’s 21st Annual Advances in Autism Conference.
Video
Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder
As part of The Friedman Brain Institute’s “FBI Cyber Series,” Rachel Yehuda, PhD, presents an exploration of the history and therapeutic use of MDMA
Video
The Mount Sinai Center for Stress, Resilience and Personal Growth
Mental health experts from Mount Sinai discuss the stress on front-line workers due to COVID-19 and the creation of the Center.
Video
The Impact of COVID-19 on Mothers and Babies
Veerle Bergink, MD, PhD, discusses mental health during pregnancy and the postpartum period during COVID-19, including potential long-term effects on the child’s brain.
Video
Speech and Language Analysis for COVID-19
Cheryl Corcoran, MD, discusses how speech and language markers can be used to track physiology and psychiatric sequelae related to COVID-19 course together with other variables and biomarkers.
Latest Articles
News
Psychiatry Specialty Report 2021
As a response to COVID-19, we created a Center for Stress, Resilience, and Personal Growth to provide mental health services to our staff, faculty, students, and trainees. Services include individualized assessments, planning, and coaching; ...
News
New Center for Computational Psychiatry
Since its inception in the early 2010s, computational psychiatry has become one of the fastest growing and most exciting areas in neuropsychiatry
News
New Approach to Treating Depression: KCNQ2/3 Channel
Initial evidence in humans for the KCNQ2/3 channel as a new target for novel drug discovery for depression and anhedonia
News
Road to Resilience Podcast: The Therapeutic Promise of Psychedelics
Listen or read the transcript of this informative podcast with Rachel Yehuda, PhD, on the potential of MDMA to treat patients with post-traumatic stress disorder
News
Mount Sinai Health System Launches Center for Psychedelic Research
New research center will focus on studying MDMA, psilocybin, and other psychedelic compounds to treat post-traumatic stress disorder, depression, and other psychological conditions
News
Five Things to Know About Providing Psychiatric Care to COVID-19 Heath Care Workers
Health care workers will likely be facing significant mental health consequences due to their involvement with COVID-19. Check out the top five things to know about providing psychiatric care to these health care workers during and after the pandemic.
News
COVID-19 and Employee Mental Health: A Five-Tier Model of Support
New York City is an epicenter of COVID-19 pandemic in the United States, and the Mount Sinai Health System has spearheaded an array of clinical and organizational innovations to mitigate the crisis.
News
Five Things to Know About Esketamine
In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and Drug Administration (FDA) to treat patients with treatment-resistant depression (TRD). James Murrough, MD, ...
